Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Minoxidil effectively treats female pattern hair loss.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Menopause affects hair and skin; more research needed for treatment.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.